carteolol has been researched along with Alloxan Diabetes in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saitoh, Y | 1 |
| Tani, T | 1 |
| Asahi, Y | 1 |
| Man, Z | 1 |
| Kawano, K | 1 |
| Ikunaga, H | 1 |
1 other study available for carteolol and Alloxan Diabetes
| Article | Year |
|---|---|
Improving effect of carteolol on bodyweight and carbohydrate and lipid metabolic responses in the OLETF rat.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Blood Glucose; Body Weight; Carteolol; Cholest | 1997 |